Morgan Stanley analyst Stephen Byrd maintains Sunrun (NASDAQ:RUN) with a Overweight and raises the price target from $86 to $91.
Wolfe Research Initiates Coverage On Sotera Health with Outperform Rating, Announces Price Target of $26
Wolfe Research analyst Mike Polark initiates coverage on Sotera Health (NASDAQ:SHC) with a Outperform rating and announces Price Target of $26.